FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377202005: Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501597013 Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676787012 Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1202518011 Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215429010 Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1478578015 Aspirin+carisoprodol+codeine phosphate 325mg/200mg/16mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3490402010 Product containing aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3494183016 Product containing aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501597013 Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569141012 Product containing only aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569142017 Product containing only aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676787012 Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676788019 Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Aspirin compound preparation (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Product containing codeine phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Substance with morphinan structure and opioid receptor agonist mechanism of action (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Product containing aspirin and carisoprodol and codeine phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carisoprodol false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Oral aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Codeine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Carisoprodol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Carisoprodol false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Carisoprodol false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Codeine phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Codeine phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator value 16 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Aspirin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator value 325 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Aspirin (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has presentation strength numerator value 325 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has precise active ingredient Carisoprodol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has precise active ingredient Codeine phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Aspirin- and carisoprodol- and codeine-containing product in oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has precise active ingredient Aspirin (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Is a Aspirin and carisoprodol and codeine only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has precise active ingredient Codeine phosphate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Codeine phosphate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has basis of strength substance (attribute) Carisoprodol true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has precise active ingredient Carisoprodol true Inferred relationship Existential restriction modifier (core metadata concept) 2
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Plays role Antitussive therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start